Health and social care workers who felt under greater pressure from their employers to receive COVID-19 vaccination were more likely to decline it, according to preliminary new research highlighting factors influencing uptake.
So, the third wave is officially no more. New modelling by SPI-M, the government’s committee on modelling for pandemics, has, at a stroke, eradicated the predicted surge in new infections, hospital admissions and deaths which it had pencilled in for the autumn or winter as a result of lockdown being eased.
…As Philip Thomas explained here on Sunday, Imperial College has also assumed strangely low estimates for the number of people in Britain carrying antibodies. If you are going to use assumptions that are far more pessimistic than real world data suggests, it is small wonder that SPI-M keeps predicting waves and surges that turn out to be wide of the mark. The question is: why are these modelling teams using such negative assumptions?
So in recent weeks I’ve made a clear decision no longer merely to point out what it is that governments and their advisers and spokespersons around the world are doing is wrong, scientifically unjustified and harmful, but to join the dots in an attempt to provide potential explanations of why they’re doing these things.
…Why do I say this? Simply because there is no benign interpretation of the acts of commission and omission consistently imposed upon us and no explanation of the statements which are flatly wrong other than an intention to deceive the population.
…It is my deduction and conclusion that the only motivation that fits all the observations is the intention to ‘herd’ every citizen into a VaxPass system. This is a completely novel system. Never before have all individuals been represented in a single, interoperable database as a unique digital ID, accompanied by an editable health-related field. Whoever controls that database, and the algorithms which govern what it permits and denies, has literally totalitarian control of the entire population. There is no personal threshold crossing or transaction which doesn’t fall to those operating that system.
Professor Neil Ferguson struck an unusually optimistic tone this week. With just one Covid death reported on Monday, and infection levels at an eight-month low in the UK, the architect of the original lockdown said: ‘The data is very encouraging and very much in line with what we expected.’ The first half of that statement is certainly true; the second half much less so.
All under-40s are to be offered an alternative to the Oxford-AstraZeneca coronavirus vaccine as a precaution.
I won’t have been the only parent concerned by news last week that the Pfizer vaccine may be approved for use on children as early as June and potentially rolled out to school pupils from September. Healthy children are at almost no serious risk from Covid-19 – the recovery rate for this age group has been calculated at over 99.99 per cent. The argument that children should have the vaccine is not based on a belief that they need or benefit from it but on the logic that it would be good for our communities at large if children were jabbed. In short, those advocating it assume that children have an obligation to protect adults.
It’s worth noting that the UK Government has granted immunity from liability for harms to all Covid-19 vaccine manufacturers. Can we really ask children to accept a greater risk than the manufacturers themselves are prepared to live with?
Danish authorities have opted for a more cautious path, even though Reuters reported that excluding J&J’s shot could significantly delay the country’s vaccination efforts.
Danish drug officials last month abandoned the use of AstraZeneca’s Covid-19 vaccine, also citing the risk of blood clots. In March, Denmark became the first country in the world to temporarily suspend the AstraZeneca shot, but unlike its European neighbors, the country made that suspension permanent.
More than 500 people who received their coronavirus jabs have been admitted to hospital with Covid-19, a UK study has found.
Researchers at Liverpool University said the patients had all received one dose of the vaccine at least three weeks before they were admitted.
They said the patients were largely frail and elderly, while the number of people who were hospitalised represented only around 1 per cent of the 52,000 people involved in the research.
The open letter states that “a good society cannot be created by an obsessive focus on a single cause of ill-health” and states all restrictions should be lifted in June on the final date in Prime Minister Boris Johnson’s ‘roadmap’ out of lockdown. Masks should no longer be worn by schoolchildren after May 17, say the scientists – and they warn the damage to society will be too great if the current Covid control measures continue beyond the June roadmap date.
Vaccine passports should also be scrapped along with mass community testing, they say.
Instead, the government should focus on targeted testing, creating better incentives for staying home if ill and basic hygiene measures, such as handwashing and surface cleaning.
Signatories (in alphabetical order)
Professor Ryan Anderson, Translational Science, Medicines Discovery Catapult
Dr Colin Axon, Mechanical Engineering, Brunel University
Professor Anthony Brookes, Genomics and Bioinformatics, University of Leicester
Professor Jackie Cassell, FFPH, Deputy Dean, Brighton and Sussex Medical School
Professor Angus Dalgleish, FRCP, FRCPath, FMedSci, Oncology, St George’s, University of London
Professor Robert Dingwall, FAcSS, HonMFPH, Sociology, Nottingham Trent University
Professor Sunetra Gupta, Theoretical Epidemiology, University of Oxford
Professor Carl Heneghan, MRCGP, Centre for Evidence Based Medicine, University of Oxford
Professor Mike Hulme, Human Geography, University of Cambridge.
Dr John Lee – formerly Pathology, Hull York Medical School
Professor David Livermore, Medical Microbiology, University of East Anglia.
Professor Paul McKeigue Genetic Epidemiology and Statistical Genetics, University of Edinburgh
Professor David Paton, Industrial Economics, University of Nottingham
Emeritus Professor Hugh Pennington, CBE, FRCPath, FRCP (Edin), FMedSci, FRSE, Bacteriology, University of Aberdeen
Dr Gerry Quinn, Biomedical Sciences, University of Ulster
Dr Roland Salmon, MRCGP, FFPH, former Director of the Communicable Disease Surveillance Centre (Wales).
Emeritus Professor John Scott, CBE, FRSA, FBA, FAcSS, Sociology, University of Essex
Professor Karol Sikora, FRCR, FRCP, FFPM, Medicine, University of Buckingham
Professor Ellen Townsend, Psychology, University of Nottingham
Dr Chao Wang, Health & Social Care Statistics, Kingston University and St George’s, University of London,
Professor John Watkins, Epidemiology, Cardiff University
Professor Lisa White, Modelling and Epidemiology, University of Oxford.
Under-40s may be offered an alternative to the Oxford-AstraZeneca vaccine after blood clot reports doubled, reports claim.
The chance of dying from a blood clot after having the jab is about one in one million – with 19 fatalities from around 20 million vaccinations. However, the total number of people in the UK who developed blood clots after getting one dose has gone from 79 to 168 in a fortnight, Medical Healthcare Products and Regulatory Agency (MHRA) data suggests.
Dr. Sucharit Bhakdi, a Thai-German microbiologist, discusses mRNA vaccines, blood clots and Cerebral Venous Thrombosis. He warned about the vaccine side-effects months before the roll-out and appears to have been proven correct.
Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement.
Many of the vaccines developed to protect against COVID-19 are forms of messenger RNA (mRNA) vaccines.
The Moderna and Pfizer/BioNTech vaccines are forms of mRNA vaccine.
Unlike the Pfizer/BioNTech and Moderna coronavirus vaccines, the Oxford/AstraZeneca vaccine is not an mRNA vaccine.
Instead, the AstraZeneca vaccine is a viral vector vaccine made from a weakened form of a common cold virus from chimpanzees.
Among 827 participants who had a completed pregnancy, the pregnancy resulted in a live birth in 712 (86.1%), in a spontaneous abortion in 104 (12.6%), in stillbirth in 1 (0.1%), and in other outcomes (induced abortion and ectopic pregnancy) in 10 (1.2%). A total of 96 of 104 spontaneous abortions (92.3%) occurred before 13 weeks of gestation (Table 4), and 700 of 712 pregnancies that resulted in a live birth (98.3%) were among persons who received their first eligible vaccine dose in the third trimester. Adverse outcomes among 724 live-born infants — including 12 sets of multiple gestation — were preterm birth (60 of 636 among those vaccinated before 37 weeks [9.4%]), small size for gestational age (23 of 724 [3.2%]), and major congenital anomalies (16 of 724 [2.2%]); no neonatal deaths were reported at the time of interview. Among the participants with completed pregnancies who reported congenital anomalies, none had received Covid-19 vaccine in the first trimester or periconception period, and no specific pattern of congenital anomalies was observed. Calculated proportions of pregnancy and neonatal outcomes appeared similar to incidences published in the peer-reviewed literature
Robin Hauser, a pediatrician in Tampa, Florida, got COVID in February. What separates her from the vast majority of the tens of millions of other Americans who have come down with the virus is this: She got sick seven weeks after her second dose of the Pfizer-BioNTech vaccine.
- Moderna CEO Stephane Bancel says Moderna is a platform company.
- mRNA is like software.
- Flu vaccines have 60% efficacy in a good year and 20%-30% efficacy in a good year.
- Moderna’s goal is to combine the Covid boost with the flu vaccine into one single dose.
- Mass vaccination centre in Nice opened at 9am Saturday offering 4,000 AstraZeneca jabs to teachers, policemen and other at-risk staff aged over 55
- But it was forced to close by 1pm after just 58 people signed up for the jabs
- It is thought 3,000 teachers were eligible for the jabs but did not want to take it
- Local official said people ‘turned around’ after learning jab was AstraZeneca
Johnson & Johnson privately reached out to Covid-19 vaccine rivals to ask them to join an effort to study the risks of blood clots and speak with one voice about safety, but Pfizer Inc. and Moderna Inc. declined.
A study by Oxford University found the number of people who receive blood clots after getting vaccinated with a coronavirus vaccine are about the same for those who get Pfizer and Moderna vaccines as they are for the AstraZeneca vaccine that was produced with the university’s help. According to the study, 4 in 1 million people experience cerebral venous thrombosis after getting the Pfizer or Moderna vaccine, versus 5 in 1 million people for the AstraZeneca vaccine. The risk of getting CVT is much higher for those who get COVID-19 — 39 in a million patients — than it is for those for get vaccinated. AstraZeneca’s vaccine use has been halted or limited in many countries on blood clot concerns.
- Luke Garrett, 20, died after suffering a seizure in Tarbolton, South Ayrshire
- Mr Garrett had muscular dystrophy and had been shielding for around a year
- But he died in the early hours of the morning the day after getting the jab
- Mother Tricia Garrett, 49, believes son would still be alive if he didn’t get the jab
- MHRA are investigating his death but there’s no evidence of jab causing seizures